☆ 4.6 Review

Acrodermatitis continua of Hallopeau and generalised pustular psoriasis: Should they be the same or different entities

EXPERIMENTAL DERMATOLOGY (2023)

Related references

Note: Only part of the references are listed.

Letter Dermatology

A case of acrodermatitis continua of Hallopeau evolving into generalized pustular psoriasis successfully treated with guselkumab

Hiroki Yamamoto et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2023)

Add to Collection

Review Dermatology

Pathophysiology of Generalized Pustular Psoriasis

Slaheddine Marrakchi et al.

Summary: Generalized pustular psoriasis (GPP) is a rare and severe form of the disease, distinct from plaque psoriasis. Dysregulation of the IL-36 signaling pathway appears central to the pathogenesis of GPP. Treatment targeting the IL-36 inflammatory cascade shows promise, although specific therapeutic agents for GPP are currently lacking.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2022)

Add to Collection

Review Dermatology

Treatment Options and Goals for Patients with Generalized Pustular Psoriasis

James Krueger et al.

Summary: Generalized pustular psoriasis (GPP) is a rare and severe skin disorder without approved specific therapies. Current treatment options are based on limited evidence and recent advances have identified potential targets for targeted therapy based on improved understanding of the disease mechanisms and gene mutations associated with GPP.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2022)

Add to Collection

Review Dermatology

Clinical Course and Characteristics of Generalized Pustular Psoriasis

Siew Eng Choon et al.

Summary: Generalized pustular psoriasis (GPP) is a rare and potentially dangerous disease characterized by the appearance of large sterile pustules in widespread areas, with or without systemic inflammation and/or plaque psoriasis. The severity and frequency of flares vary among individuals, and severe flares are often accompanied by systemic symptoms and other extracutaneous manifestations. The clinical course of GPP is highly variable.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2022)

Add to Collection

Article Allergy

Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis

Patrick Baum et al.

Summary: This study revealed that the IL-36 pathway plays a significant role in the pathogenesis of generalized pustular psoriasis. Treatment with spesolimab, an anti-IL-36 receptor antibody, resulted in rapid improvement of skin and pustular symptoms in patients with GPP. The treatment also modulated dysregulated molecular pathways associated with GPP and PPP, leading to improved clinical outcomes.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Add to Collection

Letter Dermatology

Acrodermatitis continua of Hallopeau: Is apremilast an efficacious treatment option?

Matteo Megna et al.

DERMATOLOGIC THERAPY (2022)

Add to Collection

Article Dermatology

Treatments and outcomes of generalized pustular psoriasis: A cohort of 1516 patients in a nationwide inpatient database in Japan

Hideaki Miyachi et al.

Summary: This study aimed to report treatments and outcomes among a large cohort of hospitalized patients with generalized pustular psoriasis (GPP). The study found that biologic treatments showed favorable outcomes compared with other treatments.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)

Add to Collection

Article Dermatology

Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographic and clinical comparative study in a large multicentre cohort

F. Assan et al.

Summary: Our study compared the epidemiological and clinical characteristics of palmoplantar pustulosis (PPP) and acrodermatitis continua of Hallopeau (ACH). PPP was associated with female sex, smoking activity, and higher body mass index compared to ACH. PPP also had a higher frequency of family history of psoriasis. Both PPP and ACH had similar age of onset for palmoplantar disease. Peripheral joint inflammatory involvement was only associated with ACH. The association with another psoriasis type was similar for both PPP and ACH.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2022)

Add to Collection

Article Immunology

Clinical Characteristics of Patients with Pustular Psoriasis: A Single-Center Retrospective Observational Study

Paolo Gisondi et al.

Summary: Clinical and epidemiologic data on pustular psoriasis are limited. This study investigated the phenotypes and patients' characteristics of pustular psoriasis. The results showed that pustular psoriasis is much rarer than plaque psoriasis, with palmoplantar pustulosis being the most common subtype.

VACCINES (2022)

Add to Collection

Article Medicine, General & Internal

Trial of Spesolimab for Generalized Pustular Psoriasis

H. Bachelez et al.

Summary: In a phase 2 randomized trial, spesolimab, an interleukin-36 receptor inhibitor, showed a higher rate of lesion clearance in GPP patients compared to placebo, but was associated with risks of infections and systemic drug reactions. Further longer and larger trials are needed to assess the efficacy and safety of spesolimab in patients with pustular psoriasis.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Review Dermatology

Similarity and difference between palmoplantar pustulosis and pustular psoriasis

Toshiyuki Yamamoto

Summary: Palmoplantar pustulosis is a chronic inflammatory disorder with similarities to psoriasis, but also has distinct characteristics such as familial occurrence and joint involvement. Japanese patients with this condition have a unique association with focal infection, leading to differences in clinical features and treatment approaches.

JOURNAL OF DERMATOLOGY (2021)

Add to Collection

Letter Dermatology

Inhibition of Progression of Acrodermatitis Continua of Hallopeau With Baricitinib

Guang-Ming Han et al.

Summary: This case report details a condition where pustules form beneath the fingernails, accompanied by redness and swelling of the distal interphalangeal joints.

JAMA DERMATOLOGY (2021)

Add to Collection

Article Dermatology

Unmet Medical Needs in the Treatment and Management of Generalized Pustular Psoriasis Flares: Evidence from a Survey of Corrona Registry Dermatologists

Bruce Strober et al.

Summary: This study surveyed 29 eligible dermatologists to identify key features of GPP flares, suggesting the need for consensus guidelines for diagnosis and management. While moderately effective therapies may exist, there remains a need for GPP-specific treatments.

DERMATOLOGY AND THERAPY (2021)

Add to Collection

Review Dermatology

Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options

Alan Menter et al.

Summary: Pustular psoriasis is a rare form of psoriasis that poses clinical challenges for dermatologists. It presents with pustules and erythema, with two distinct subtypes. Treatment is often based on existing therapies, but there are limitations and challenges in managing the condition.

DERMATOLOGY AND THERAPY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Pustular Psoriasis: From Pathophysiology to Treatment

Giovanni Genovese et al.

Summary: Pustular psoriasis is a clinicopathological entity with different variants characterized by sterile pustules on an erythematous base, showing intense inflammatory response and involvement of the IL-36 axis. Due to the rarity and heterogeneity of PP forms, data on prognosis and therapeutic management are limited, leading to ongoing debates on the diagnosis and treatment of PP.

BIOMEDICINES (2021)

Add to Collection

Article Medicine, General & Internal

Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare

Siew Eng Choon et al.

Summary: Effisayil 1 is a global Phase II placebo-controlled study aiming to evaluate the efficacy, safety, and tolerability of spesolimab in patients presenting with an acute GPP flare. At least 51 patients will be randomized to receive a single 900 mg intravenous dose of spesolimab or placebo and followed for up to 28 weeks, with primary and key secondary endpoints focusing on skin improvement. The study complies with ethical principles and will be disseminated in a peer-reviewed journal.

BMJ OPEN (2021)

Add to Collection

Review Immunology

Generalized pustular psoriasis: current management status and unmet medical needs in Japan

Mayumi Komine et al.

Summary: Generalized pustular psoriasis (GPP) is a rare, inflammatory skin disease with potentially life-threatening systemic symptoms. While there are approved systemic therapies in Japan for GPP, there is uncertainty regarding their safety and efficacy, especially in treating acute phase GPP. New therapies targeting the interleukin-36 pathway have shown promise in this patient population, but the rarity and intermittent nature of GPP pose challenges for robustly investigating their efficacy and safety.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2021)

Add to Collection

Article Dermatology

Epidemiology and clinical features of pustular psoriasis: A 15-year retrospective cohort

Theetouch Tosukhowong et al.

Summary: Pustular psoriasis (PuP) is a rare variant of psoriasis, with the most prevalent subtype being Generalized PuP (GPP), often triggered by corticosteroid withdrawal, upper respiratory tract infection, and pregnancy. Treatment mainly involves oral acitretin and topical corticosteroids.

JOURNAL OF DERMATOLOGY (2021)

Add to Collection

Article Dermatology

26591 Characterization of flares in patients with generalized pustular psoriasis—A population-based study from the French National Health Data System database (SNDS)

Hervé Bachelez et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)

Add to Collection

Review Dermatology

Palmoplantar pustulosis: Current understanding of disease definition and pathomechanism

Masamoto Murakami et al.

JOURNAL OF DERMATOLOGICAL SCIENCE (2020)

Add to Collection

Article Dermatology

Treatment of acrodermatitis continua of Hallopeau: A case series of 39 patients

Christian Kromer et al.

JOURNAL OF DERMATOLOGY (2020)

Add to Collection

Letter Dermatology

Three cases of IL36RN-associated pustulosis: An evolution of acrodermatitis continua of Hallopeau to generalized pustular psoriasis

Yun-Liu Chen et al.

INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY (2020)

Add to Collection

Review Dermatology

Pustular Psoriasis: The Dawn of a New Era

Herve Bachelez

ACTA DERMATO-VENEREOLOGICA (2020)

Add to Collection

Article Allergy

Clinical and genetic differences between pustular psoriasis subtypes

Sophie Twelves et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)

Add to Collection

Letter Medicine, General & Internal

Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis

Herve Bachelez et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection

Review Dermatology

The Use of Biologic Therapy in the Treatment of Acrodermatitis Continua of Hallopeau: A Review

Khalad Maliyar et al.

JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2019)

Add to Collection

Letter Dermatology

Successful treatment of acrodermatitis continua of Hallopeau with apremilast

Yuichi Kurihara et al.

JOURNAL OF DERMATOLOGY (2019)

Add to Collection

Article Dermatology

Zwei Fälle von Acrodermatitis continua suppurativa (Morbus Hallopeau) unter Behandlung mit IL‐17A‐Hemmern

Emilia Schmid et al.

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2019)

Add to Collection

Letter Dermatology

Apremilast as a new treatment option for Acrodermatitis continua of Hallopeau

Alba Calleja Algarra et al.

AUSTRALASIAN JOURNAL OF DERMATOLOGY (2019)

Add to Collection

Review Dermatology

Acrodermatitis continua of Hallopeau: clinical perspectives

Mary Patricia Smith et al.

PSORIASIS-TARGETS AND THERAPY (2019)

Add to Collection

Review Dermatology

Highlighting Interleukin-36 Signalling in Plaque Psoriasis and Pustular Psoriasis

Kazuhisa Furue et al.

ACTA DERMATO-VENEREOLOGICA (2018)

Add to Collection

Review Dermatology

Pustular psoriasis and related pustular skin diseases

H. Bachelez

BRITISH JOURNAL OF DERMATOLOGY (2018)

Add to Collection

Letter Dermatology

A case of acrodermatitis continua of Hallopeau (ACH) successfully treated with sulfasalazine

Mi Li et al.

DERMATOLOGIC THERAPY (2018)

Add to Collection

Letter Dermatology

Japanese guidelines for the management and treatment of generalized pustular psoriasis: The new pathogenesis and treatment of GPP

Hideki Fujita et al.

JOURNAL OF DERMATOLOGY (2018)

Add to Collection

Article Dermatology

Efficacy and safety of brodalumab in patients with generalized pustular psoriasis and psoriatic erythroderma: results from a 52-week, open-label study

K. Yamasaki et al.

BRITISH JOURNAL OF DERMATOLOGY (2017)

Add to Collection

Article Dermatology

Successful response in a case of severe pustular psoriasis after interleukin-1β inhibition

P. Skendros et al.

BRITISH JOURNAL OF DERMATOLOGY (2017)

Add to Collection

Article Dermatology

Clinical profiles of pediatric patients with GPP alone and with different IL36RN genotypes

Yirong Wang et al.

JOURNAL OF DERMATOLOGICAL SCIENCE (2017)

Add to Collection

Review Dermatology

European consensus statement on phenotypes of pustular psoriasis

A. A. Navarini et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)

Add to Collection

Letter Dermatology

Novel Application of High-Dose-Rate Brachytherapy for Severe, Recalcitrant Acrodermatitis Continua of Hallopeau

Joanie Pinard et al.

JAMA DERMATOLOGY (2017)

Add to Collection

Article Dermatology

Acrodermatitis Continua of Hallopeau with Bone Resorption in an 8-Year-Old Patient: A Case Report

May Alorainy et al.

CASE REPORTS IN DERMATOLOGY (2017)

Add to Collection

Article Dermatology

Correlation of IL36RN mutation with different clinical features of pustular psoriasis in Chinese patients

Ting-Shun Wang et al.

ARCHIVES OF DERMATOLOGICAL RESEARCH (2016)

Add to Collection

Letter Dermatology

A Case of Acrodermatitis Continua Accompanying with Osteolysis and Atrophy of the Distal Phalanx That Evoluted into Generalized Pustular Psoriasis

Kyung Ho Kim et al.

ANNALS OF DERMATOLOGY (2016)

Add to Collection

Article Dermatology

AP1S3 Mutations Cause Skin Autoinflammation by Disrupting Keratinocyte Autophagy and Up-Regulating IL-36 Production

Satveer K. Mahil et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)

Add to Collection

Article Dermatology

Treatment of two patients with generalized pustular psoriasis with the interleukin-1β inhibitor gevokizumab

B. Mansouri et al.

BRITISH JOURNAL OF DERMATOLOGY (2015)

Add to Collection

Letter Allergy

IL36RN mutations define a severe autoinflammatory phenotype of generalized pustular psoriasis

Safia Hussain et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)

Add to Collection

Article Dermatology

Clinical features and course of generalized pustular psoriasis in Korea

Hyunju Jin et al.

JOURNAL OF DERMATOLOGY (2015)

Add to Collection

Article Dermatology

Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis Vulgaris

Dorottya M. Berki et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)

Add to Collection

Review Cell Biology

Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions

Cem Gabay et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2015)

Add to Collection

Review Dermatology

Acrodermatitis Continua of Hallopeau Treated Successfully with Ustekinumab and Acitretin after Failure of Tumour Necrosis Factor Blockade and Anakinra

Jordane Saunier et al.

DERMATOLOGY (2015)

Add to Collection

Article Genetics & Heredity

AP1S3 Mutations Are Associated with Pustular Psoriasis and Impaired Toll-like Receptor 3 Trafficking

Niovi Setta-Kaffetzi et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2014)

Add to Collection

Letter Dermatology

Successful therapy with anakinra in a patient with generalized pustular psoriasis carrying IL36RN mutations

U. Hueffmeier et al.

BRITISH JOURNAL OF DERMATOLOGY (2014)

Add to Collection

Article Dermatology

Clinical profile, morbidity, and outcome of adult-onset generalized pustular psoriasis: analysis of 102 cases seen in a tertiary hospital in Johor, Malaysia

Siew Eng Choon et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2014)

Add to Collection

Review Dermatology

Acrodermatitis continua of Hallopeau (ACH): Two cases successfully treated with adalimumab

Luisa Di Costanzo et al.

JOURNAL OF DERMATOLOGICAL TREATMENT (2014)

Add to Collection

Letter Dermatology

Rare Pathogenic Variants in IL36RN Underlie a Spectrum of Psoriasis-Associated Pustular Phenotypes

Niovi Setta-Kaffetzi et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)

Add to Collection

Article Dermatology

The Majority of Generalized Pustular Psoriasis without Psoriasis Vulgaris Is Caused by Deficiency of Interleukin-36 Receptor Antagonist

Kazumitsu Sugiura et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)

Add to Collection

Letter Dermatology

Mutations in IL36RN in Patients with Generalized Pustular Psoriasis

Andreas Koerber et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)

Add to Collection

Article Dermatology

Acrodermatitis continua of hallopeau evolving into generalised pustular psoriasis

DevinderM Thappa et al.

INDIAN JOURNAL OF DERMATOLOGY (2013)

Add to Collection

Review Dermatology

Treatment of pustular psoriasis: From the Medical Board of the National Psoriasis Foundation

Amanda Robinson et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)

Add to Collection

Article Dermatology

Clinical and Laboratory Features in Acute Generalized Pustular Psoriasis A Retrospective Study of 34 Patients

Joao Borges-Costa et al.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2011)

Add to Collection

Review Dermatology

Acrodermatitis continua of Hallopeau: evolution of treatment options

Virendra N. Sehgal et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2011)

Add to Collection

Review Dermatology

Treatment of Acrodermatitis Continua of Hallopeau with TNF-Blocking Agents: Case Report and Review

Lluis Puig et al.

DERMATOLOGY (2010)

Add to Collection

Article Dermatology

An Infant with Acrodermatitis Continua of Hallopeau: Successful Treatment with Thalidomide and UVB Therapy

Ana Elisa Kiszewski et al.

PEDIATRIC DERMATOLOGY (2009)

Add to Collection

Article Dermatology

Therapeutic guidelines for the treatment of generalized pustular psoriasis (GPP) based on a proposed classification of disease severity

Y Umezawa et al.

ARCHIVES OF DERMATOLOGICAL RESEARCH (2003)

Add to Collection

Article Dermatology

Pathophysiology of generalized pustular psoriasis

H Iizuka et al.

ARCHIVES OF DERMATOLOGICAL RESEARCH (2003)

Add to Collection

Article Dermatology

Pustular psoriasis of the nails: treatment and long-term follow-up of 46 patients

BM Piraccini et al.

BRITISH JOURNAL OF DERMATOLOGY (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.